{
  "zip": "B3H 0A8",
  "sector": "Healthcare",
  "longBusinessSummary": "Appili Therapeutics Inc., a biopharmaceutical company, acquires, develops, and commercializes novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1501, a taste-masked oral liquid suspension formulation of an antibiotic, metronidazole; ATI-1503 that develops a class of gram-negative targeting antibiotics; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. Appili Therapeutics Inc. was founded in 2015 and is headquartered in Halifax, Canada.",
  "city": "Halifax",
  "phone": "902 442 4655",
  "state": "NS",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.appilitherapeutics.com",
  "maxAge": 1,
  "address1": "#21-1344 Summer Street",
  "industry": "Biotechnology",
  "previousClose": 0.88,
  "regularMarketOpen": 0.8636,
  "twoHundredDayAverage": 0.8916,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.88,
  "navPrice": null,
  "averageDailyVolume10Day": 10460,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.88,
  "fiftyDayAverage": 0.8916,
  "trailingAnnualDividendRate": null,
  "open": 0.8636,
  "averageVolume10days": 10460,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.8636,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 13018,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 53731796,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 10460,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.8636,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 13018,
  "fiftyTwoWeekHigh": 0.91,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.8636,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 0.88,
  "exchange": "PNK",
  "shortName": "APPILI THERAPEUTICS INC",
  "longName": "Appili Therapeutics Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "APLIF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_330222442",
  "uuid": "df37bddd-c23d-386d-a253-a2f33cea7c20",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 62284200,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1585612800,
  "heldPercentInstitutions": 0.32426,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1648684800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 51568217,
  "enterpriseValue": 54810112,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.8636,
  "logo_url": "https://logo.clearbit.com/appilitherapeutics.com"
}